Skip to content

Molnupiravir

Molnupiravir is an antiviral for mild to moderate Coronavirus Disease 2019 (COVID-19) in adults at risk of severe disease. One product sits on this shelf: Movfor, a 200 mg capsule.

Movfor

Coronavirus Disease 2019 (COVID-19)

200mg

Molnupiravir capsules for covid-19. It forces the virus to make copying errors so it cannot multiply.

From$4.39/ capsuleView

Key points

  • Molnupiravir belongs to the antiviral class and works by stopping SARS-CoV-2 from spreading in the body.
  • It has not received standard regulatory approval; it is available only under an Emergency Use Authorization for certain adults.
  • Molnupiravir may cause harm to an unborn baby and is not recommended in pregnancy or for anyone under 18 years of age.

Treatment positioning

Movfor is Hetero Healthcare’s brand of molnupiravir, listed in the Antivirals category. NICE recommends molnupiravir only when both nirmatrelvir plus ritonavir and sotrovimab cannot be used or are unsuitable for the patient.

Further reading